Myelodysplastic Syndrome
-
New therapeutic strategy for leukemia syndrome
Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy. Read MoreApr 20, 2021
-
One-two punch for cancer
A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients. Read MoreMar 5, 2020
-
Myelodysplastic syndrome event scheduled for March 14
Vanderbilt-Ingram Cancer Center’s Michael Savona, associate professor of medicine and director of the Hematology Early Therapeutics Program, will headline a seminar on new therapies and treatment options for patients with myelodysplastic syndrome. Read MoreMar 11, 2015
-
Visit unites stem cell transplant patient, donor for first time
When Darlena Clark of Hendersonville, Tennessee, saw Jon Strong for the first time at Nashville International Airport she, “just grabbed him and hugged him and just held on.” Read MoreDec 11, 2014